EXHIBIT 23.1


            CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


The Board of Directors
Nastech Pharmaceutical Company Inc.:

We consent to the use of our reports dated March 15, 2006, with respect to the
consolidated balance sheets of Nastech Pharmaceutical Company Inc. as of
December 31, 2005 and 2004, the related consolidated statements of operations,
stockholders' equity and comprehensive loss and cash flows for each of the years
in the three-year period ended December 31, 2005, management's assessment of the
effectiveness of internal control over financial reporting as of December 31,
2005, and the effectiveness of internal control over financial reporting as of
December 31, 2005, incorporated herein by reference and to the reference to our
firm under the heading "Experts" in the prospectus.


/s/ KPMG LLP
- --------------

KPMG LLP


Seattle, WA
July 11, 2006